Microbiome Diagnostics Market Top Companies Study - Yakult Honsha Co., AOBiome, Enterome Biosciences SA, Metabiomics Corp.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Microbiome Diagnostics Market - (By Product (Reagents & Kits, Instruments), By Technology (16S rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics, Other Technology), By Sample (Feces, Saliva, Skin, Other Sample), By Application (Disease Diagnostics Application (Gastrointestinal Disorders, Metabolic Diseases, Other Application), Research Application), By End-User (Hospitals, Academic and Research Institutes, Biotechnology and Pharmaceutical Companies)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Microbiome Diagnostics Market is valued at US$ 154.9 Mn in 2023, and it is expected to reach US$ 488.2 Mn by 2031, with a CAGR of 15.6% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2398

Microbiome diagnostics entails examining the microbial communities residing within and on the human body to detect alterations linked to diseases, disorders, or general health conditions. The human microbiome, comprising bacteria, viruses, fungi, and other microbes, has a vital impact on health and disease, affecting processes such as digestion, immunological function, and even behaviour. Technological and bioinformatic developments have made microbiome analysis more precise and thorough. Innovative diagnostic techniques for a range of applications, such as infectious illnesses, personalized medicine, and gastrointestinal problems, have been developed as a result of market demand. Further driving market development are growing investments in microbiome research and partnerships between academic institutions and biotechnology firms. However, issues like regulatory barriers and testing technique standardization still exist, reshaping this quickly changing business.

List of Prominent Players in the Microbiome Diagnostics Market:
• Yakult Honsha Co.
• AOBiome
• Enterome Biosciences SA
• Metabiomics Corp.
• Microbiome Therapeutics LLC
• Osel, Inc.
• Rebiotix, Inc.
• Second Genome
• Seres Therapeutics
• Synthetic Biologics, Inc.
• Vedanta Biosciences
• 4D Pharma
• Du Pont De Nemours and Co.
• Ferring Pharmaceuticals
• Genetic Analysis AS
• Atlas Biomed
• Biome Oxford Ltd.
• Illumina Inc.
• Microba Life Sciences
• Dna Genotek (Orasure Technologies, Inc.)
• Viome Life Sciences
• Sun Genomics
• Becton, Dickinson And Company
• Daytwo
• OraSure Technologies, Inc.
• Other Market Players

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics:
Drivers-
Research and education on the human microbiome are key drivers of the Microbiome Diagnostics Market. The microbiome diagnostics market size is expanding as, through alliances, industry associates and academic researchers operate cohesively to advance contemporary microbiome-dependent diagnostics instruments and stretch the knowledge of the character of the microbiome in health and disease. These partnerships generate opportunities for contemporary diagnostic commodities dependent on the microbiome and ease the passage of fundamental research unearthing into clinical usage. Ongoing scientific research increases understanding of the microbiome's role in health and disease, spurring demand for diagnostic tools. Educational initiatives raise awareness among healthcare professionals and the public, fostering the adoption of microbiome-based diagnostics for personalized medicine and improved patient outcomes. Awareness about healthy lifestyles is another significant driver of market growth.

Challenges:
High processing and manufacturing costs are major hindrances to market growth. Complex manufacturing processes, including compression molding and continuous lamination, increase production expenses. Additionally, the limited availability of raw materials further drives up costs. High costs associated with the research and development proficiencies, limited infrastructural facilities, and inadequate research on the human microbiome are expected to obstruct market growth. Despite continuing endeavours by governments and private firms globally to administer funding and research, several research and educational establishments, however, come across budgetary restrictions when it comes to obtaining and using progressive and expensive instruments and technologies.

Regional Trends:
North America is the region in the Microbiome Diagnostics Market, which is expected to register as a major market revenue share due to a well-established environmental as well as automotive infrastructure. Also, due to the major players in the region. The Microbiome Diagnostics Market exhibits regional variations influenced by factors such as increasing demand from the industry and economic conditions. Developed regions are due to their export-oriented nature, while emerging economies show growing demand for organosheets driven by the requirement for lightweight materials.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2398

Recent Developments
• In July 2022, OraSure Technologies, Inc. has made its OMNIgene®•GUT DNA and RNA product (OMR-205) available to researchers studying the gut microbiota. OraSure technology is a prominent worldwide frontrunner in the field of point-of-care and home diagnostic testing, as well as sample collecting technology. The product facilitated the collection, preservation, storage, and transfer of microbial DNA and RNA at room temperature for the purpose of analyzing the gut microbiome. The product was manufactured by DNA Genotek, a subsidiary of OraSure.
• In Aug 2021, A partnership between Second Genome and Arena Pharmaceuticals to identify gastrointestinal biomarkers was recently disclosed. A proof-of-concept study utilizing microbiome signals was conducted by Second Genome as part of Arena's CULTIVATE Phase 2/3 clinical trial for Crohn's disease.

Market Segmentation-
By Product-
• Reagents & Kits
• Instruments
By Technology-
• 16S rRNA Sequencing
• Shot Gun Metagenomics
• Metatranscriptomics
• Other Technology
By Sample-
• Feces
• Saliva
• Skin
• Other Sample
By Application-
• Disease Diagnostics Application
o Gastrointestinal Disorders
o Metabolic Diseases
o Other Application
• Research Application
By End-User-
• Hospitals
• Academic and Research Institutes
• Biotechnology and Pharmaceutical Companies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.